Meeting the Challenge of Designing AI Scribes for Specialties
Nextech CEO Rusty Frantz details the launch of Cora Scribe with an early focus on ophthalmology
Read More
How One Leading DSO Used Analytics to Drive a 26% Increase in Crown Treatment Planning Rates
[Sponsored] A recent webinar sponsored by Overjet offered insights from Affinity Dental Management executives on how AI-driven clinical intelligence software can transform DSOs. The post How One Leading DSO Used Analytics to Drive a 26% Increase in Crown Treatment Planning Rates appeared first on MedCity News.
When Suicidal Calls Come In, Who Answers? Georgia Crisis Line Response Rates Reveal Gaps
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” Kaitlin Cooke of Cartersville, Georgia, was contemplating suicide when she started calling a statewide mental health crisis line in 2018. She said she would sneak outside and call the hotline…
Which Digital Health Startups Will Win in 2026?
Investors at Breyer Capital think 2026 could mark a turning point in digital health, as logistics become as important as scientific innovation. They highlighted three key trends shaping the market: shifting biotech constraints from biology to delivery, bottom-up product adoption by clinicians, and a wave of consolidation among AI startups. The post Which Digital Health…
Doctors Trade Group: Medicare Advantage Rate Proposal ‘Will Impair’ Care Capacity
CMS officials have proposed a payment increase of less than 0.1 percent for 2027. Investors slammed shares of prominent insurance companies in response.
AMN Executives: Staffing Market Ready to Enter New Growth Cycle
At the recent J.P. Morgan conference, CEO Cary Grace said clients are, after the turmoil of the COVID era, back to focusing more on combining efficient spending with finding and keeping talent.
Roche Obesity Drug’s Phase 2 Results Are Competitive, But True Test May Come From Combo Studies
Preliminary Phase 2 data show Roche’s CT-388 led to a 22.5% placebo-adjusted weight loss measured at 48 weeks. Based on these results, the pharmaceutical company plans to advance the GLP-1 and GIP agonist to a Phase 3 clinical trial in obesity. The post Roche Obesity Drug’s Phase 2 Results Are Competitive, But True Test May…
Wisp Acquires Sexual Health Platform TBD Health
This is Wisp’s first acquisition, for which the terms of the deal were not disclosed. It allows the company to expand into providing in-person care to complement its virtual support. The post Wisp Acquires Sexual Health Platform TBD Health appeared first on MedCity News.
Hackensack Meridian to Deploy Lumeris’ AI Tool in MSSP ACO
Lumeris says ‘Tom’ platform to enable tracking, performance management, and scalable best-next-action workflows embedded in clinical operations
Cada vez más médicos ven con buenos ojos a los asistentes de IA. Pero aún hay tropiezos
Cuando Jeannine Urban fue a un chequeo médico en noviembre, tuvo toda la atención de su doctora. En lugar de teclear en su computadora durante la consulta, la médica de atención primaria de Urban, en la práctica Penn Internal Medicine en Media, Pennsylvania, usó un asistente de inteligencia artificial (IA) conocido como ambiental para tomar notas. Al…